Serotonin transporter (SERT) imbalances are involved in the pathogenesis of a wide range of neuropsychiatric diseases, including depression. SERT blockers, like citalopram, decrease radioligand binding to the SERT in a dose-dependent manner, as measured with SPECT. In addition to replicating this finding, we show that pharmacological MRI (phMRI) can also detect differences in SERT occupancy with different oral doses of citalopram; higher citalopram plasma levels are associated with lower subsequent changes in the phMRI signal upon an intravenous citalopram challenge. This is important as this non-ionizing technique allows longitudinal assessment of the serotonin system.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords